331 related articles for article (PubMed ID: 20156921)
1. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.
Mirza FS; Padhi ID; Raisz LG; Lorenzo JA
J Clin Endocrinol Metab; 2010 Apr; 95(4):1991-7. PubMed ID: 20156921
[TBL] [Abstract][Full Text] [Related]
2. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
Garnero P; Sornay-Rendu E; Munoz F; Borel O; Chapurlat RD
Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
[TBL] [Abstract][Full Text] [Related]
3. Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.
Polyzos SA; Anastasilakis AD; Bratengeier C; Woloszczuk W; Papatheodorou A; Terpos E
Osteoporos Int; 2012 Mar; 23(3):1171-6. PubMed ID: 21305266
[TBL] [Abstract][Full Text] [Related]
4. Determinants of serum sclerostin in healthy pre- and postmenopausal women.
Ardawi MS; Al-Kadi HA; Rouzi AA; Qari MH
J Bone Miner Res; 2011 Dec; 26(12):2812-22. PubMed ID: 21812027
[TBL] [Abstract][Full Text] [Related]
5. Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women.
Drake MT; Srinivasan B; Mödder UI; Peterson JM; McCready LK; Riggs BL; Dwyer D; Stolina M; Kostenuik P; Khosla S
J Clin Endocrinol Metab; 2010 Nov; 95(11):5056-62. PubMed ID: 20631014
[TBL] [Abstract][Full Text] [Related]
6. Circulating sclerostin levels in relation to nutritional status, sex hormones and selected bone turnover biochemical markers levels in peri- and postmenopausal women.
Czajkowska M; Plinta R; Owczarek A; Olszanecka-Glinianowicz M; Skrzypulec-Plinta V
Ginekol Pol; 2019; 90(7):371-375. PubMed ID: 31392705
[TBL] [Abstract][Full Text] [Related]
7. Circulating TGF-β1 levels are negatively correlated with sclerostin levels in early postmenopausal women.
Cheng Q; Tang W; Sheu TJ; Du Y; Gan J; Li H; Hong W; Zhu X; Xue S; Zhang X
Clin Chim Acta; 2016 Apr; 455():87-92. PubMed ID: 26826396
[TBL] [Abstract][Full Text] [Related]
8. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity.
Grethen E; Hill KM; Jones R; Cacucci BM; Gupta CE; Acton A; Considine RV; Peacock M
J Clin Endocrinol Metab; 2012 May; 97(5):1655-62. PubMed ID: 22362819
[TBL] [Abstract][Full Text] [Related]
9. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women.
Sheng Z; Tong D; Ou Y; Zhang H; Zhang Z; Li S; Zhou J; Zhang J; Liao E
Clin Endocrinol (Oxf); 2012 Jun; 76(6):797-801. PubMed ID: 22151063
[TBL] [Abstract][Full Text] [Related]
10. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
11. Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes.
Zhou YJ; Li A; Song YL; Zhou H; Li Y; Tang YS
Chin Med Sci J; 2013 Sep; 28(3):135-9. PubMed ID: 24074614
[TBL] [Abstract][Full Text] [Related]
12. Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol.
Cheng Q; Wu X; Du Y; Hong W; Tang W; Li H; Chen M; Zheng S
Clin Interv Aging; 2018; 13():2367-2374. PubMed ID: 30532527
[TBL] [Abstract][Full Text] [Related]
13. Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women.
He J; Zhang H; Wang C; Zhang Z; Yue H; Hu W; Gu J; Fu W; Hu Y; Li M; Liu Y; Zheng H; Zhang Z
J Clin Endocrinol Metab; 2014 Apr; 99(4):E665-73. PubMed ID: 24423318
[TBL] [Abstract][Full Text] [Related]
14. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
[TBL] [Abstract][Full Text] [Related]
15. Serum sclerostin levels decline in post-menopausal women with osteoporosis following treatment with intermittent parathyroid hormone.
Piemonte S; Romagnoli E; Bratengeier C; Woloszczuk W; Tancredi A; Pepe J; Cipriani C; Minisola S
J Endocrinol Invest; 2012 Oct; 35(9):866-8. PubMed ID: 22842667
[TBL] [Abstract][Full Text] [Related]
16. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.
Amrein K; Amrein S; Drexler C; Dimai HP; Dobnig H; Pfeifer K; Tomaschitz A; Pieber TR; Fahrleitner-Pammer A
J Clin Endocrinol Metab; 2012 Jan; 97(1):148-54. PubMed ID: 21994959
[TBL] [Abstract][Full Text] [Related]
17. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.
Mödder UI; Hoey KA; Amin S; McCready LK; Achenbach SJ; Riggs BL; Melton LJ; Khosla S
J Bone Miner Res; 2011 Feb; 26(2):373-9. PubMed ID: 20721932
[TBL] [Abstract][Full Text] [Related]
18. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study.
Khosla S; Atkinson EJ; Melton LJ; Riggs BL
J Clin Endocrinol Metab; 1997 May; 82(5):1522-7. PubMed ID: 9141544
[TBL] [Abstract][Full Text] [Related]
19. Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.
Costa AG; Walker MD; Zhang CA; Cremers S; Dworakowski E; McMahon DJ; Liu G; Bilezikian JP
J Clin Endocrinol Metab; 2013 Dec; 98(12):4736-43. PubMed ID: 24037879
[TBL] [Abstract][Full Text] [Related]
20. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
Xu XJ; Shen L; Yang YP; Lu FR; Zhu R; Shuai B; Li CG; Wu MX
Chin Med J (Engl); 2013 Jul; 126(13):2480-4. PubMed ID: 23823821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
